Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases

被引:41
作者
Guise, Theresa A. [1 ]
机构
[1] Indiana Univ, Sch Med, Dept Internal Med, Indianapolis, IN 46202 USA
关键词
EGFR; bone metastasis; breast cancer; metalloprotease; osteoclastogenesis; TRANSFORMING-GROWTH-FACTOR; EGF-LIKE LIGANDS; PROSTATE-CANCER; MATRIX METALLOPROTEINASES; OSTEOCLAST DIFFERENTIATION; SKELETAL COMPLICATIONS; TISSUE INHIBITOR; ZOLEDRONIC ACID; LUNG-CANCER; PHASE-II;
D O I
10.1101/gad.1854909
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Bone metastases are the most common skeletal complication of malignancy. Tumor cells disrupt normal bone remodeling to promote bone destruction and its associated morbidity. In the August 15, 2009, issue of Genes & Development, Lu and colleagues (pp. 1882-1894) propose a novel molecular mechanism by which tumor-produced metalloproteinases release epidermal growth factor (EGF) ligands to activate the central osteoclastogenic pathway receptor activator of NF-kappa B ligand (RANKL) to promote breast cancer osteolysis. This work has important therapeutic applications that may quickly translate to more effective treatment for bone metastases.
引用
收藏
页码:2117 / 2123
页数:7
相关论文
共 59 条
[31]  
Lipton A, 2001, SEMIN ONCOL, V28, P54, DOI 10.1053/sonc.2001.25438
[32]   Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively [J].
Liu, YJ ;
Xu, Y ;
Yu, Q .
ONCOGENE, 2006, 25 (17) :2452-2467
[33]   EFFECTS OF DNA AND PROSTAGLANDIN SYNTHESIS INHIBITORS ON THE STIMULATION OF BONE-RESORPTION BY EPIDERMAL GROWTH-FACTOR IN FETAL-RAT LONG-BONE CULTURES [J].
LORENZO, JA ;
QUINTON, J ;
SOUSA, S ;
RAISZ, LG .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1897-1902
[34]   ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis [J].
Lu, Xin ;
Wang, Qiongqing ;
Hu, Guohong ;
Van Poznak, Catherine ;
Fleisher, Martin ;
Reiss, Michael ;
Massague, Joan ;
Kang, Yibin .
GENES & DEVELOPMENT, 2009, 23 (16) :1882-1894
[35]   MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL [J].
Lynch, CC ;
Hikosaka, A ;
Acuff, HB ;
Martin, MD ;
Kawai, N ;
Singh, RK ;
Vargo-Gogola, TC ;
Begtrup, JL ;
Peterson, TE ;
Fingleton, B ;
Shirai, T ;
Matrisian, LM ;
Futakuchi, M .
CANCER CELL, 2005, 7 (05) :485-496
[36]   Pharmacologic Inhibition of the TGF-β Type I Receptor Kinase Has Anabolic and Anti-Catabolic Effects on Bone [J].
Mohammad, Khalid S. ;
Chen, Carol G. ;
Balooch, Guive ;
Stebbins, Elizabeth ;
McKenna, C. Ryan ;
Davis, Holly ;
Niewolna, Maria ;
Peng, Xiang Hong ;
Nguyen, Daniel H. N. ;
Ionova-Martin, Sophi S. ;
Bracey, John W. ;
Hogue, William R. ;
Wong, Darren H. ;
Ritchie, Robert O. ;
Suva, Larry J. ;
Derynck, Rik ;
Guise, Theresa A. ;
Alliston, Tamara .
PLOS ONE, 2009, 4 (04)
[37]   Metastasis to bone: Causes, consequences and therapeutic opportunities [J].
Mundy, GR .
NATURE REVIEWS CANCER, 2002, 2 (08) :584-593
[38]   Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner [J].
Nabha, Sanaa M. ;
dos Santos, Emanuel Burck ;
Yamamoto, Hamilto A. ;
Belizi, Abdelfettah ;
Dong, Zhong ;
Meng, Hong ;
Saliganan, Allen ;
Sabbota, Aaron ;
Bonfil, R. Daniel ;
Cher, Michael L. .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (11) :2482-2490
[39]   MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival [J].
Nakopoulou, L ;
Tsirmpa, I ;
Alexandrou, P ;
Louvrou, A ;
Ampela, C ;
Markaki, S ;
Davaris, PS .
BREAST CANCER RESEARCH AND TREATMENT, 2003, 77 (02) :145-155
[40]   Correlation of tissue inhibitor of metalloproteinase-2 with proliferative activity and patients' survival in breast cancer [J].
Nakopoulou, L ;
Katsarou, S ;
Giannopoulou, I ;
Alexandrou, P ;
Tsirmpa, I ;
Panayotopoulou, E ;
Mavrommatis, J ;
Keramopoulos, A .
MODERN PATHOLOGY, 2002, 15 (01) :26-34